Back to today’s briefing

Story perspectives

India Boosts Drug Inspections After Maternal Deaths Crisis

2/23/2025

50 7

Summary

Story summary

In a decisive move to enhance drug safety, the Indian government has ramped up inspections at over 500 pharmaceutical units since 2022, taking action against more than 400 non-compliant manufacturers. The urgency has intensified following maternal deaths in Karnataka linked to contaminated injectables, sparking demands for stricter regulations and improved oversight.

1 of 1

Story summary

In a decisive move to enhance drug safety, the Indian government has ramped up inspections at over 500 pharmaceutical units since 2022, taking action against more than 400 non-compliant manufacturers. The urgency has intensified following maternal deaths in Karnataka linked to contaminated injectables, sparking demands for stricter regulations and improved oversight.